Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis

BACKGROUND: The impact of smoking on TNF inhibition (TNFi) therapy is unclear. We examined the effect of smoking on all-cause and cause-specific TNFi discontinuation in axial spondyloarthritis (axSpA). METHODS: We used longitudinal data from the British Society for Rheumatology Biologics Register fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Sizheng Steven, Yoshida, Kazuki, Jones, Gareth T., Hughes, David M., Duffield, Stephen J., Tedeschi, Sara K., Lyu, Houchen, Moots, Robert J., Solomon, Daniel H., Goodson, Nicola J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647300/
https://www.ncbi.nlm.nih.gov/pubmed/31331375
http://dx.doi.org/10.1186/s13075-019-1958-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647300/
https://www.ncbi.nlm.nih.gov/pubmed/31331375
http://dx.doi.org/10.1186/s13075-019-1958-z

Ejemplares similares